107 results on '"BOGUNIEWICZ, Mark"'
Search Results
2. Dupilumab Consistently Reduces CCL-17 (TARC) in Patients with Atopic Dermatitis Across All Age Groups
3. Dupilumab Improves Skin Lipid Barrier in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis
4. Cutaneous Ceramide Synthase 1 (CERS1) Gene Expression is a Biomarker of Staphylococcus aureus Abundance and Severity of Atopic Dermatitis
5. Topical Treatments for Atopic Dermatitis: Systematic Review and Network Meta-Analysis of Randomized Trials
6. Lebrikizumab Maintains Improvements in the Patient-Oriented Eczema Measure Through 2 Years of Treatment in Patients With Moderate-to-Severe Atopic Dermatitis
7. Systemic Treatments for Atopic Dermatitis: Systematic Review and Network Meta-Analysis of Randomized Trials
8. Tapinarof Validates the Aryl Hydrocarbon Receptor as a Therapeutic Target: A Clinical Review
9. The role of Janus kinase signaling in the pathology of atopic dermatitis
10. Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment
11. Dupilumab inhibits vascular leakage of blood proteins into atopic dermatitis skin
12. Dupilumab Reduces Inflammatory Biomarkers in Patients Aged 6 Months to 18 Years With Moderate-to-Severe or Severe Atopic Dermatitis
13. Dupilumab Treatment Reduces Total IgE Levels in Patients 6 Months and Older with Moderate-to-Severe Atopic Dermatitis
14. Dupilumab Efficacy in Children With Atopic Dermatitis Aged 6 Months to 5 Years With and Without Atopic Comorbidities
15. Efficacy of Lebrikizumab in Patients With Atopic Dermatitis and Atopic Comorbidities: Pooled Results From Two Phase 3 Monotherapy Randomized, Double-Blind, Placebo-Controlled 16-Week Studies (ADvocate1 and ADvocate2)
16. Effect of Abrocitinib and Dupilumab on Eosinophil Levels in Patients With Moderate-to-Severe Atopic Dermatitis and With or Without Comorbid Asthma or Allergic Rhinitis: A Post Hoc Pooled Analysis of JADE COMPARE and JADE DARE
17. Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms
18. Dupilumab treatment significantly improves skin barrier function in adult and adolescent patients with moderate to severe atopic dermatitis
19. Are skin microbes with lantibiotic biosynthesis genes reduced in atopic dermatitis subjects who are culture positive for Staphylococcus aureus?
20. Efficacy of Abrocitinib Rescue Therapy in the Phase 3 Study JADE REGIMEN
21. Effect of Dupilumab on the Host-Microbe Interface in Atopic Dermatitis
22. Dupilumab Improves Signs And Symptoms Of Severe Atopic Dermatitis In Children Aged 6–11 Years With And Without Comorbid Asthma
23. Depth and Rapidity of Response With Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis (AD) in JADE COMPARE
24. Efficacy of Dupilumab in Adolescents With Moderate-to-Severe Atopic Dermatitis With and Without Comorbid Asthma: Subgroup Analysis From a Phase 3 Trial
25. Report from the National Institute of Allergy and Infectious Diseases workshop on “Atopic dermatitis and the atopic march: Mechanisms and interventions”
26. Nonlesional Atopic Dermatitis Skin Shows Alterations in Langerhans Cells in Close Proximity to Tight Junction Fragmentation
27. Measurement properties of Hospital Anxiety and Depression Scale used in atopic dermatitis in adults
28. Dupilumab Improves Outcomes of Concurrent Asthma and Chronic Sino-Nasal Conditions in Patients With Atopic Dermatitis—a Pooled Analysis of Four Phase 3 Studies (LIBERTY AD SOLO 1 & 2, CHRONOS, and CAFÉ)
29. Patients with adult- and late childhood-onset atopic dermatitis report a higher burden of disease severity than patients with early childhood-onset atopic dermatitis.
30. Staphylococcus Aureus -Culture Positivity Observed In Adults With Atopic Dermatitis Is Most Indicative Of An Increased Absolute and Relative Abundance Of S. Aureus and Not Reduced Biodiversity
31. Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines
32. Skin Lipid Composition Varies Based on Clinical Subphenotypes in Adult European American Atopic Dermatitis Subjects
33. Distinct Features Identified in Adult Atopic Dermatitis Subjects Based on Age of Onset
34. Interaction Between the R501X Filaggrin Mutation and Disease Severity Associates with Increased Staphylococcus Aureus Colonization in European American Subjects with Atopic Dermatitis
35. Efficacy and Safety of Crisaborole Topical Ointment, 2%, a Novel, Nonsteroidal, Topical, Anti-Inflammatory, Phosphodiesterase Inhibitor in 2 Phase 3 Studies in Children and Adults with Mild-to-Moderate Atopic Dermatitis
36. Targeted therapy for allergic diseases: At the intersection of cutting-edge science and clinical practice
37. Exome Chip Genotyping Reveals Association With PDE4C and Atopic Dermatitis In Populations Of European and African Descent
38. The ABC's of managing patients with severe atopic dermatitis
39. Biomarkers of Disease Severity and Th2 Polarity Are Predictors of Atopic Dermatitis Subjects Who Are Colonized with S. Aureus
40. Exome Chip Genotyping Reveals Association with LAMA3 (laminin, alpha 3) Gene and Eczema Herpeticum in a Population of European Descent
41. Atopic dermatitis: A practice parameter update 2012
42. The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infections
43. Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis
44. Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response
45. Tight junction defects in patients with atopic dermatitis
46. Immune response to varicella vaccine in children with atopic dermatitis compared with nonatopic controls
47. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum
48. Vaccinia virus–specific molecular signature in atopic dermatitis skin
49. Recent insights into atopic dermatitis and implications for management of infectious complications
50. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.